U.S. imports of large commercial aircraft surged 190.56% month-over-month in February 2026, reaching $1.23 billion — up from just $423.5 million in January. That single data point signals either a major deferred delivery catching up or a deliberate front-loading ahead of anticipated trade policy changes. Either way, it's the most dramatic percentage swing among February's top movers.
Headline Numbers: A Mixed Picture
Total U.S. imports for February 2026 came in at $253.6 billion, a 2.68% decline from January. Exports, meanwhile, climbed 4.7% to $195.1 billion, narrowing — but not closing — a trade deficit that still stands at $58.4 billion. The divergence between falling imports and rising exports is worth watching: it may reflect seasonal patterns, but the commodity-level data tells a more targeted story.
Aircraft Imports: A 190% Spike Demands Attention
Large aircraft (HS 880240, unladen weight over 15,000 kg) posted the highest percentage gain of any tracked commodity, jumping from $423.5 million to $1.23 billion. For airlines and lessors, this kind of month-over-month swing typically reflects the lumpy nature of aircraft deliveries — a handful of wide-body jets can move the needle significantly. Supply chain teams tracking aerospace logistics should note this as a potential signal of accelerated delivery schedules.
Pharmaceutical Surge Across Multiple Categories
Three pharmaceutical and biochemical categories posted triple-digit percentage increases in February, and together they represent a coordinated pattern worth flagging. Immunological products (HS 300214) surged 164.85% to $1.02 billion, while nucleic acids and heterocyclic compounds (HS 293499) jumped 174.05% to $779.0 million. Hormones and related dosage-form products (HS 300439) more than doubled, rising 101.33% to $620.0 million.
This broad-based pharmaceutical surge — spanning biologics, active pharmaceutical ingredients, and finished dosage forms — is consistent with importers building inventory buffers. With ongoing uncertainty around pharmaceutical tariff policy, procurement teams appear to be pulling forward orders rather than waiting for clarity.
Digital Processing Units: The Quiet Giant
While percentage swings in pharma and aircraft grab headlines, the sheer dollar volume of digital processing unit imports (HS 847150) is the story that matters most for supply chain planners. At $22.2 billion — up 9.49% from $20.3 billion in January — this single HTS code accounts for nearly 8.8% of all U.S. imports in February. Solid-state semiconductor storage devices (HS 852351) added another $2.91 billion, up 16.29%, and automatic data processing storage units (HS 847170) contributed $1.69 billion, up 21.45%.
Combined, these three computing and storage categories totaled over $26.8 billion in February alone. For technology importers and data center operators, the sustained elevation of these figures points to continued strong demand — and continued exposure to any tariff action targeting electronics from key Asian suppliers.
Commercial Vehicles: Two Categories, Both Climbing
Motor vehicles for goods transport posted notable gains across two weight classes. Light commercial trucks with spark-ignition engines under 5 metric tons GVW (HS 870431) rose 24.47% to $1.90 billion. Heavier diesel-engine goods vehicles over 5 metric tons (HS 870422) surged 90.64% to $601.1 million. The parallel increases across both categories suggest broad demand from logistics and freight operators, not a one-off procurement event.
Petroleum Products: A Quieter But Significant Move
Light petroleum oils and preparations (HS 271012) climbed 29.77% to $1.27 billion, up from $978.8 million in January. This category — covering refined petroleum products with greater than 70% petroleum content — is sensitive to both seasonal demand shifts and refinery run rates. A nearly 30% monthly increase warrants monitoring, particularly for energy traders and fuel distributors managing Q1 inventory positions.
What This Means for Trade Professionals
The February data presents a clear theme: importers across pharmaceuticals, technology, and commercial vehicles are moving volume aggressively. Whether driven by genuine demand growth or precautionary stockpiling ahead of potential tariff changes, the effect on port throughput, warehousing capacity, and working capital requirements is the same — pressure is building.
Supply chain managers sourcing in any of these categories should be stress-testing their logistics capacity and payment terms now. The commodity-level concentration in computing hardware and pharma APIs also means that any targeted trade action in these sectors would have outsized balance-of-trade consequences relative to their product count.